Categories: DiagnosticsLegalTechPlatform
Biosensia developed RapiPlex, a point-of-care diagnosis system based on proprietary technologies capable of producing quantitative and qualitative laboratory quality test results.
Biosensia merged with Kypha in 2018, a USA based in-vitro diagnostics company, to co-develop immune and inflammation assays on the Biosensia point-of-care RapiPlex platform.
Copyright © 2024 Seroba. All rights reserved.
Legal | Privacy | Sustainability
Investors 1
Funding Rounds 1
Date | Series | Amount | Investors |
19.12.2011 | - | $1.56M | - |
Mentions in press and media 1
Reviews 0